CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Significant impact of the presence of type 2 diabetes on the cardiovascular risk conferred by the plasminogen activator inhibitor-1–675 5G/4G polymorphism
DOI 10.1055/s-2007-984788
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Muendlein, CH Saely, T Marte, L Koch, F Schmid, P Rein, S Aczel, P Langer
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe07/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background/Aims: The -675 5G/4G polymorphism of the plasminogen activator inhibitor-1 (PAI-1) gene has been associated with increased plasma levels of PAI-1 and, in some studies, with increased vascular risk. Hardly any data on the vascular risk conferred by this polymorphism are available for patients with type 2 diabetes (T2DM). We therefore aimed at investigating i) the association of this polymorphism with angio…
Zitieren
Zitierempfehlung
A Muendlein, CH Saely, T Marte, L Koch, F Schmid, P Rein, S Aczel, P Langer (2007) Significant impact of the presence of type 2 diabetes on the cardiovascular risk conferred by the plasminogen activator inhibitor-1–675 5G/4G polymorphism. Diabetologie und Stoffwechsel (07). https://doi.org/10.1055/s-2007-984788
Mit CareLit weiterarbeiten